Digitoxigenin is a cardenolide aglycone derived from cardiac glycosides like digitoxin, typically obtained from plants such as Digitalis purpurea. As a member of the cardiac glycoside class, it exerts… Read more
Digitoxigenin is a cardenolide aglycone derived from cardiac glycosides like digitoxin, typically obtained from plants such as Digitalis purpurea. As a member of the cardiac glycoside class, it exerts its biological effect by inhibiting the Na+/K+-ATPase pump, which increases intracellular calcium levels and enhances myocardial contractility. Because of its potent pharmacological activity and potential toxicity, rigorous analytical monitoring is essential during pharmaceutical development. This category contains Digitoxigenin reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These high-quality materials are critical for accurate impurity profiling, method validation, and rigorous quality control testing in pharmaceutical research, ensuring that analysts can reliably identify and quantify trace-level components in drug substances and formulations throughout the development lifecycle.